Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

750
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
750
Dementia01:30

Dementia

226
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
226
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

293
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
293
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

373
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Risks of Mortality, Cardiovascular Events, and Pulmonary Complications in Cancer Patients Who Smoke Cigarettes and Switch to E-Cigarettes: South Korea, 2015‒2022.

American journal of public health·2026
Same author

Development of Virtual Reality Health Literacy: Delphi Expert Consensus Study.

Journal of medical Internet research·2026
Same author

Long-term Particulate Matter Exposure and Risk of Alopecia Areata: A Nationwide Epidemiological Study with Preliminary In Vitro Evidence.

The British journal of dermatology·2026
Same author

COVID-19 Vaccination Effectiveness and Clinical Outcomes in Chronic Liver Disease: A Nationwide Retrospective Cohort Study.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Clopidogrel Monotherapy in Patients With Chronic Coronary Syndrome Following Coronary Artery Bypass Grafting: A Nationwide Cohort Study.

Korean circulation journal·2026
Same author

Loneliness and health-related quality of life by chronic disease: a nationally representative survey.

International journal of epidemiology·2026
Same journal

The Role of YouTube as an Information Platform for Ovarian Cancer: the Educational Quality and Reliability.

Yonsei medical journal·2026
Same journal

Bone Bridge Effect for the Treatment of Acute Osteoporotic Vertebral Compression Fractures: A Multistrategic Approach Using an Anabolic Agent.

Yonsei medical journal·2026
Same journal

Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy.

Yonsei medical journal·2026
Same journal

The Risk of Incident Diabetes Mellitus in Relation to Egg Consumption among Working-Aged Korean Adults.

Yonsei medical journal·2026
Same journal

SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone Management.

Yonsei medical journal·2026
Same journal

Optimizing Antibiotic Use for Urinary Tract Infections: A Qualitative Assessment of Regular Prescribing Practices.

Yonsei medical journal·2026
See all related articles

Related Experiment Video

Updated: Oct 16, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K

Developing a Dementia Platform Databank Using Multiple Existing Cohorts.

Minwoong Kang1,2, Bo Kyoung Cheon1,3, Min Jung Hahn3

  • 1Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.

Yonsei Medical Journal
|October 21, 2021
PubMed
Summary
This summary is machine-generated.

This pilot study explored integrating dementia cohorts, facing challenges with variable data. Establishing protocols early is crucial for future dementia research data harmonization.

Keywords:
Dementiacohortdatabaseplatform

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Related Experiment Videos

Last Updated: Oct 16, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Area of Science:

  • Neuroscience
  • Gerontology
  • Data Science

Background:

  • Integrating diverse dementia cohorts is essential for large-scale research.
  • Existing dementia patient data often exists in separate, non-interoperable cohorts.
  • Challenges in data harmonization hinder the creation of comprehensive dementia research platforms.

Purpose of the Study:

  • To evaluate the feasibility of building an integrated dementia platform.
  • To converge pre-existing dementia cohorts from multiple sources.
  • To identify barriers and propose solutions for cohort data integration.

Main Methods:

  • Pilot project integrating four distinct dementia cohorts: CREDOS, K-BASE, EPINEF, and DPKR.
  • Data from 29,916 patients were analyzed with 348 integrated variables.
  • Assessment of data variability and missing information across cohorts.

Main Results:

  • Successfully integrated data from 29,916 patients across four cohorts.
  • Identified significant variability in study variables and measurements as a key integration barrier.
  • High rates of missing information (≥50%) were noted for lifestyle and demographic variables.

Conclusions:

  • Integrating pre-existing dementia cohorts presents significant challenges due to data heterogeneity.
  • A standardized protocol considering data integration from the cohort establishment stage is necessary.
  • Future efforts should focus on developing robust data harmonization strategies for dementia research.